Compare ImmunityBio Inc. Common Stock (IBRX) vs NIO Inc. (NIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs NIO Inc. — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while NIO Inc. trades at $3.46 (market cap $8.67B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and NIO Inc. for 81 Days on average.
| IBRX | NIO | |
|---|---|---|
Market Cap | $10.33B | $8.67B |
Volume | 11,745,198 | 25,622,800 |
Sector | Health | Consumer Cyclical |
52-Week High | $11.55 | $7.46 |
52-Week Low | $1.98 | $3.37 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $10.79B | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NIO trades at $3.41, down 2.01% today and near its 52-week low of $3.38. The stock shows bearish technical signals with negative moving averages, though oscillators are neutral. Fundamentally, revenue grew to $87.49B in 2025 with improving net margin to -17.8%, but the company remains unprofitable with negative ROE of -332.77%. Recent news highlights a strategic battery-swap partnership with Geely, valued at $2.38B, which could expand NIO's charging network reach.
The outlook remains challenging amid a brutal EV price war in China, though analyst consensus is bullish with a $6.23 price target implying 83% upside. Key risks include persistent losses, high debt, and intense competition. Institutional sentiment is mixed with 50% buy ratings, but the stock's current valuation at 0.51 P/S may attract value investors betting on a long-term turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
